e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Asthma: breath biomarkers and asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of salbutamol, formoterol and ipratropium bromide on exhaled nitric oxide in asthmatic patients and healthy volunteers
G. Strazda, M. Bukovskis, N. Jurka, Z. Balode, L. Balode, I. Taivans (Riga, Latvia)
Source:
Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Session:
Asthma: breath biomarkers and asthma control
Session type:
Thematic Poster Session
Number:
1285
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Strazda, M. Bukovskis, N. Jurka, Z. Balode, L. Balode, I. Taivans (Riga, Latvia). Effect of salbutamol, formoterol and ipratropium bromide on exhaled nitric oxide in asthmatic patients and healthy volunteers. Eur Respir J 2010; 36: Suppl. 54, 1285
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled
Source: Eur Respir J 2005; 26: Suppl. 49, 617s
Year: 2005
Influence of fluticasone propionate on levels of exhaled nitric oxide in asthmatic children: a dose response study
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001
Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Inhaled fluticasone diproprionate decreases levels of nitric oxide in recurrently wheezy infants
Source: Eur Respir J 2003; 22: Suppl. 45, 388s
Year: 2003
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
Source: Eur Respir J 2004; 23: 559-564
Year: 2004
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: a SOMA study
Source: Eur Respir J 2006 Oct 01;28(4):748-755
Year: 2006
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge
Source: Eur Respir J 2009; 33: 747-753
Year: 2009
Effect of flunisolide and nitric oxide (NO)-releasing flunisolide on silicosis in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005
Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Influence of spirometry and bronchodilator test procedures in exhaled nitric oxide values in asthmatic children
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept